US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist
  • 4.250
  • +0.270+6.78%
Close Dec 2 16:00 ET
  • 4.250
  • 0.0000.00%
Post 16:02 ET
125.84MMarket Cap-5483P/E (TTM)

Telomir Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Telomir Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--------
--------
--------

Unlock Free Earnings Estimates

Telomir Pharmaceuticals Earnings Reports

  • Telomir Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:50 ET

  • Telomir Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:09 ET

  • Telomir Pharmaceuticals | 10-Q: Quarterly report

    May 13 16:36 ET

  • Telomir Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 29 17:33 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data